Leading the Way in Life Science Technologies

GEN Exclusives

More »
ANVISA - Related Content
  • Columns: Biosimilars in Brazil
    Revised ANVISA guidelines encourage development of biologics and biosimilars in Brazil in response to an increasing demand for development there.

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »